CHICAGO -- A no-scalpel vasectomy passed a preliminary clinical test, achieving near-100% azoospermia within 2 weeks and maintaining the status to day 30 in the first men to undergo the procedure.
Decision based on data involving use of SpaceOAR® hydrogel to protect surrounding tissue during radiotherapy to treat prostate cancer. BEDFORD, Mass.--(BUSINESS WIRE)--Augmenix, Inc., a medical ...
AUSTIN, Texas, Nov. 18, 2025 /PRNewswire/ -- Alafair Biosciences, Inc., a medical device company redefining soft-tissue protection in orthopedic surgery, announced today the first clinical use of its ...
The cornea is the transparent part of the coating of the eyeball, which covers the iris and pupil and admits light to the interior of the eye. Injury or disease of the cornea can make it opaque, ...
BEDFORD, Mass.--(BUSINESS WIRE)-- Augmenix, Inc. is pleased to announce that the company’s leading product, SpaceOAR hydrogel, is now available to millions of American men covered under Medicare, ...
Advances in materials science are transforming medicine, engineering, and environmental technology. Among the most promising innovations are hydrogels—highly absorbent polymer networks with ...
AUSTIN, Texas, Nov. 18, 2025 /PRNewswire/ -- Alafair Biosciences, Inc., a medical device company redefining soft-tissue protection in orthopedic surgery, announced today the first clinical use of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results